3Ralhan R,Arora S,Chattopadhyay TK,et al.Circulating p53 antibodies,p53 gene mutational profile and product accumulation in esophageal squamous-cell carcinoma in India.Int J Cancer,2000,85(6):791-795.
4Soria JC,Rodriguez M,Liu DD,et al.Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers.Cancer Res,2002,62(2):351-355.
5Palmisano WA,Divine KK,Saccomanno G,et al.Predicting lung cancer by detecting aberrant promoter methylation in sputum.Cancer Res,2000,60(21):5954-5958.
6Su WC,Shiesh SC,Liu HS,et al.Expression of oncogene products HER2/Neu and Ras and fibrosis-related growth factors bFGF,TGF-beta,and PDGF in bile from biliary malignancies and inflammatory disorders.Dig Dis Sci,2001,46(7):1387-1392.
7Coulson JM,Edgson JL,Woll PJ,et al.A splice variant of the neuron-restrictive silencer factor repressor is expressed in small cell lung cancer:a potential role in derepression of neuroendocrine genes and a useful clinical marker.Cancer Res,2000,60(7):1840-1844.
8Vorwerk P,Wex H,Hohmann B,et al.CTGF (IGFBP-rP2) is specifically expressed in malignant lymphoblasts of patients with acute lymphoblastic leukaemia (ALL).Br J Cancer,2000,83(6):756-760.
9Veikkola T,Karkkainen M,Claesson-Welsh L,et al.Regulation of angiogenesis via vascular endothelial growth factor receptors.Cancer Res,2000,60(2):203-212.
10Woodman AC,Goodison S,Drake M,et al.Noninvasive diagnosis of bladder carcinoma by enzyme-linked immunosorbent assay detection of CD44 isoforms in exfoliated urothelia.Clin Cancer Res,2000,6(6):2381-2392.
